Challenge Overview

The Challenge:​

While the association between nucleotide repeat expansion toxicity and muscle and central nervous system (CNS) disorders is well-established, current strategies face challenges in effectively mitigating the toxicity

The Goal:​

We aim to collaboratively uncover and advance groundbreaking approaches for mitigating nucleotide repeat expansion toxicity

The Solution:​

We are seeking innovative strategies or novel concepts for mitigating nucleotide repeat expansion toxicity, with the potential to be applied in the treatment of muscle or CNS diseases

Contact Us

If you have any inquires please email openinnovation@astrazeneca.com